Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides (original) (raw)

• Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923 (1993).
  Article CAS Google Scholar
• Mayeux, R. et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34, 752–754 (1993).
  Article CAS Google Scholar
• van Duijin, C.M. et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genetics 7, 74–78 (1994).
  Article Google Scholar
• Hendrie, H.C. et al. Apolipoprotein E genotypes and AD in a community study of elderly African Americans. Ann. Neurol. 37, 118–120 (1995).
  Article CAS Google Scholar
• Saunders, A.M. et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472 (1993).
  Article CAS Google Scholar
• Corder, E.H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180–184 (1994).
  Article CAS Google Scholar
• Maestre, G. et al. Apolipoprotein E and Alzheimer’s disease: ethnic variation in genotypic risks. Ann. Neurol. 37, 254–259 (1995).
  Article CAS Google Scholar
• Xhignesse, M., Lussier-Cacan, S., Sing, C.F., Kessling, A.M. & Davignon, J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler. Thromb. 11, 1100–1110 (1991).
  Article CAS Google Scholar
• Stengard, J.H. et al. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91, 265–269 (1995).
  Article CAS Google Scholar
• van Bockxmeer, F.M., Mamotte, C.D., Gibbons, F.R. & Taylor, R.R. Apolipoprotein epsilon 4 homozygosity — a determinant of restenosis after coronary angioplasty. Atheroscler. 110, 195–202 (1994).
  Article CAS Google Scholar
• Schachter, F. et al. Genetic associations with human longevity at the apoE and ACE loci. Nature Genet. 6, 29–32 (1994).
  Article CAS Google Scholar
• Louhija, J. et al. Aging and genetic variation of plasma apolipoproteins. Arterioscler. Thromb. 14, 1084–1089 (1994).
  Article CAS Google Scholar
• Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704–706 (1991).
  Article CAS Google Scholar
• Pike, C.J., Burdick, D., Walencewicz, A.J., Gabe, C.G. & Cotman, C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676–1687 (1993).
  Article CAS Google Scholar
• Behl, C., Davis, J., Cole, G.M. & Schubert, D. Vitamin E protects nerve cells from amyloid βprotein toxicity. Biochem. Biophys. Res. Comm. 186, 944–950 (1992).
  Article CAS Google Scholar
• Behl, C., Davis, J., Lesley, R. & Schubert, D. Hydrogen peroxide mediates amyloid βprotein toxicity. Cell 77, 817–827 (1994).
  Article CAS Google Scholar
• Butterfield, D.A., Hensley, K., Harris, M., Mattson, M. & Carney, J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Comm. 200, 710–715 (1994).
  Article CAS Google Scholar
• Wisniewski, T. & Frangione, B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett 135, 235–238 (1992).
  Article CAS Google Scholar
• Sanan, D.A. et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860–869 (1994).
  Article CAS Google Scholar
• Ma, J., Yee, A., Brewer, H.B., Das, S. & Potter, H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92–94 (1994).
  Article CAS Google Scholar
• Nathan, B.P. et al. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264, 850–852 (1994).
  Article CAS Google Scholar
• Hartmann, H., Eckert, A. & Muller, W.E. Apolipoprotein E and cholesterol affect neuronal calcium signaling: the possible relationship between β-amyloid and neurotoxicity. Biochem. Biophys. Res. Comm. 200, 1185–1192 (1994).
  Article CAS Google Scholar
• Strittmater, W.J. et al. Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad Sci. U. S. A. 91, 11183–11186 (1994).
  Article Google Scholar
• Hayek, T., Oikinine, J., Brook, J.G. & Avriam, M. Increased plasma and lipoprotein lipid peroxidation in apolipoprotein E deficient mice. Biochem Biophys. Res. Comm. 201, 1567–1574 (1994).
  Article CAS Google Scholar
• Rinninger, F. & Pittman, R.C. Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by Hep G2 cells. J. Biol. Chem. 264, 6111–6118 (1989).
  CAS PubMed Google Scholar
• Jaeckle, S., Brady, S.E. & Havel, R.J. Membrane binding sites for plasma lipoproteins on endosomes from rat liver. Proc. Natl. Acad. Sci. U.S.A. 86, 1880–1884 (1989).
  Article CAS Google Scholar
• Weisgraber, K.H., Innerarity, T.L. & Mahley, R.W. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253, 9053–9062 (1978).
  CAS PubMed Google Scholar
• Maxwell, S.J.R., Wiklund, O. & Bondjers, G. Measurement of antioxidant activity in lipoproteins using enhanced chemiluminescence. Atheroscler. 111, 79–89 (1994).
  Article CAS Google Scholar
• Dong, L.M. et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269, 22358–22365 (1994).
  CAS PubMed Google Scholar
• Schaefer, E.J. et al. Familial apolipoprotein E deficiency. J. Clin. Invest. 78, 1206–1219 (1986).
  Article CAS Google Scholar
• Plump, A.S. et al. Severe hypercholesterolaemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).
  Article CAS Google Scholar
• Lehtimaki, T. et al. Apolipoprotein E polymorphism and its influence on apoE concentrations in cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Genet. 95, 39–42 (1995).
  Article CAS Google Scholar
• Burdick, D. et al. Assembly and aggregation properties of synthetic Alzheimer's A/4β amyloid peptide analogs. J. Biol. Chem. 267, 546–554 (1992).
  CAS PubMed Google Scholar
• Strittmatter, W.J. et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098–8102 (1993).
  Article CAS Google Scholar
• Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J. & Frangione, B. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Comm. 192, 359–365 (1993).
  Article CAS Google Scholar
• Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H. & Lansbury, P.T.J. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 92, 763–767 (1995).
  Article CAS Google Scholar
• LaDu, M.J. et al. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403–23406 (1994).
  CAS PubMed Google Scholar
• LaDu, M.J. et al. Purification of apoE attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039–9042 (1995).
  Article CAS Google Scholar
• Whitson, J.S. et al. Attenuation of the neurotoxic effect of β amyloid by apolipoprotein E. Biochem. Biophys. Res. Comm. 199, 163–170 (1994).
  Article CAS Google Scholar
• Buettner, G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300, 535–543 (1993).
  Article CAS Google Scholar
• Kunitake, S.T., Jarvis, M.R., Hamilton, R.L. & Kane, J.P. Binding of transition metals by apolipoprotein A-l-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 89, 6993–6997 (1992).
  Article CAS Google Scholar
• Ehrenwald, E., Chisolm, G.M. & Fox, P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93, 1493–1501 (1994).
  Article CAS Google Scholar
• Mantyh, P.W. et al. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61, 1171–1174 (1993).
  Article CAS Google Scholar
• Regan, L. Protein design: novel metal-binding sites. Trends Biochem. Sci. 20, 280–285 (1995).
  Article CAS Google Scholar
• Smith, J.D., Melian, A., Leff, T. & Breslow, J.L. Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. J. Biol. Chem. 263, 8300–8308 (1988).
  CAS PubMed Google Scholar
• Buege, J.A. & Aust, S.D. Microsomal lipid peroxidation. Meth. Enzymol. 52, 302–310 (1978).
  Article CAS Google Scholar